| Literature DB >> 36082217 |
Yining Lu1,2, Huw D Wiltshire2, Julien S Baker3, Qiaojun Wang1, Shanshan Ying1, Jianshe Li1, Yichen Lu4.
Abstract
The prevalence of adiposity is increasing among adult women. Although emerging evidence suggest that all patterns of heightened physical activity (PA) are important to benefit adiposity, the relationship between objectively assessed intensities of PA and adiposity in women has not yet been assessed. Therefore, this systematic review and meta-analysis aims to qualitatively synthesize and quantitatively assess the evidence for any relationship between objectively measured PA and a wide range of adiposity indicators to guide PA prescription in adult women. Four databases (PubMed, Web of Science, Scopus, and the Cochrane library) were searched for eligible studies. 35 studies were included (25 observational and 10 interventional studies), with a total of 9,176 women from 20 countries included. The overall pooled correlation for random effects model (n = 1 intervention and n = 15 cross-sectional studies) revealed that the total volume of physical activity (TPA) was moderately associated with percentage body fat (%BF) (r = -0.59; 95% CI: -1.11, -0.24; p = 0.003). There was a weak but significant association between MVPA with body mass index (BMI), waist circumference (WC), and visceral adiposity. Daily steps were significantly associated with BMI, %BF, WC, and fat mass, with the strongest association with %BF (r = -0.41; 95% CI: -0.66, -0.19; p < 0.001). Walking programs resulting in increasing daily steps only had a significant effect on WC (SMD = -0.35; 95% CI: -0.65, -0.05; p = 0.02). Overall, objectively determined PA in terms of steps, TPA and MVPA were favorably associated with adiposity outcomes. The improvement in adiposity can be achieved by simply accumulating more PA than previously and adiposity is more likely to be benefited by PA performed at higher intensity. Nonetheless, these results should be interpreted with caution as there were a small number of studies included in the meta-analysis and the majority of studies included utilized cross-sectional designs.Entities:
Keywords: accelerometer; adiposity; adult women; pedometer; physical activity
Year: 2022 PMID: 36082217 PMCID: PMC9445154 DOI: 10.3389/fphys.2022.935892
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.755
FIGURE 1PRISMA process of study selection.
Characteristics of observational studies.
| References | Study design | Country | Sample size | PA measure | Health outcome | Association |
|---|---|---|---|---|---|---|
|
| cross-sectional | Japan | 42 | A: Lifecorder-Ex; uniaxial. . Duration (min/d), frequency (bouts/d). MVPA, MVPA bout (32s, 1, 3, 5min); VPA, VPA bout (32s, 1, 3, 5min) |
| Regression: 1) Frequency of MVPA bout (1min,3min), TPA bout (3min, 5min) were favorable associated with VAT; 2) Duration of MVPA bout (1min) was favorable associated with VAT; 3) VPA was favorable associated with VAT; 4) No significant relationship between MVPA and VAT |
|
| cross-sectional | United States | 343 | A: ActiGraph GT3x; triaxial, Duration (min/d): LPA, MPA, VPA; Intensity of PA (METs) |
| Regression: adjusted for age and seasonality. 1) Duration of MPA, VPA was favorably associated with %BF, LPA had no association with %BF; 2) For every 10 min spent in MVPA per day, the odds of being obese reduced by 29%. 3) For PA intensity (≤4 METS), %BF decreased as duration increased; For PA intensity (≥4.9 METS), no benefit of accumulating more than 30 min per week. ANOVA:1) Group (VPA ≥30min/w) had significantly lower %BF than Group (VPA <30min/w); 2) Group (MVPA ≥30 min/d) had significantly lower %BF than Group (MVPA <30 min/d); 3) Group (MVPA ≥90 min/d) was associated with the lowest %BF |
|
| cross-sectional | United States | 186 | P: Omeron HJ-720-ITC. Steps (n/d) Aerobic steps (n/d) (60/min for a minimum of 10 min) |
| Regression: adjusted for age, average daily temperature, and menstrual cycle. 1) Every increase of 1,000 steps/d was associated with a 2.4% lower %BF; 2) For every increase of 1,000 steps/d, the odds of being obese reduced by 22%; 3) For Group (≥10,000 steps/d), the odds of being overweight reduced by 65% and the odds of being obese were reduced by 80% compared with Group (<10,000 steps/d)Correlation:1) Steps/d was favorably associated with %BF; has no association with WC, BMI; 2) Aerobic steps/d has no association with body composition index |
|
| cross-sectional | Netherlands | 80 | A: Tracmor IV, triaxialTPA (Mcnts/d) |
| Regression: adjusted for BM, height, and seasonality. 1) TPA was favorably associated with %BF |
|
| cross-sectional | Brazil | 49 | A: ActiGraph GT3x; triaxial. Duration (min/w): MVPATPA (counts/min) meet/not meet MVPA (Duration) |
| U-test: 1) Group (MVPA <150 min/w) had a higher %BF compared to (MVPA ≥150 min/w); 2) No differences in BMI between Group (MVPA <150 min/w) and Group (MVPA ≥150 min/w); 3) Group (NAF) had a higher TPA compared to Group (HAF); 4) No differences in %MVPA between Group (NAF) and Group (HAF) |
|
| cross-sectional | Brazil | 68 | P: BP 148. Steps (n/d) |
| t-test and U-test: 1) Group (Steps/d < 6,000) had higher BMI, WC, %BF than Group (Steps/d ≥ 6,000) |
|
| cross-sectional | United States | 50 | A: ActiGraph GT3X+; triaxial. Duration (min/d): LPA, MVPA; Duration (min/w): MVPA bout (10min) |
| Correlation: adjusted for SB, VO2peak, and BM. 1) LPA, MVPA and MVPA bouts had no association with WC |
|
| cross-sectional | United States | 69 | P: New Lifestyles Digi-Walker SW-200. Steps (n/d) |
| Correlation: adjusted for age and caloric intake. 1) Steps/d was favorably associated with BMI, %BF, WC |
|
| cross-sectional | United States | 210 | A: Kenz Lifecorder Plus; uniaxial. Duration (min/d): MVPA, MVPA bout (10min) Steps (n/d) |
| Correlation: 1) Steps/d was favorably associated with BMI, WC; 2) MVPA was favorably associated with WC; had no association with BMI; 3) MVPA bouts had no association with BMI, WC |
|
| cross-sectional | United States | 35 | P: Yamax Digi-Walker SW-200, sealed. Steps (n/d) |
| Correlation: 1) Steps/d was favorably associated with BMI; had no association with WC.ANOVA:1) Group (Steps/d < 5,000) had higher BMI compared to Group (Steps/d ≥ 5,000); 2) No differences in WC between Groups |
|
| cross-sectional | Japan | 100 | A: Lifecorder EX, uniaxial. Duration (min/d): LPA, MPA, VPASteps (n/d) |
| Regression: 1) Steps/d was favorably associated with BMI, FM and %BF; 2) LPA had no association with BMI, %BF or FM; 3) MPA was favorably associated with BMI and FM; had no association with %BF; 4) VPA was favorably associated with BMI, FM and %BF |
|
| cross-sectional | Czech Republic | 167 | A: ActiGraph GT1M, uniaxial. Duration (min/w):MPA meet MPA/do not meet MPA (Duration, Frequency)Steps (n/d) |
| Correlation: 1) MPA and steps/d were favorably associated with BMI, FM, and VAT; ANOVA: 1) Group (150 ≤ MPA≤300min/w) had higher FM than Group (MPA>300min/w); no differences in BMI and VAT between groups; 2) Group (not meet MPA 5 × 30 min/week) had higher BMI, FM, VAT than Group (meet MPA 5 × 30 min/week); 3) The frequency of performing 10,000 steps/day in a week was favorably associated with BMI, FM, VAT |
|
| cross-sectional | United States | 237 | A: RT3; triaxial. Duration (min/d): LPA, MPA, VPA, MVPA |
| K-S test: 1) MVPA was higher in Group (weight-loss-maintainer) than Group (always-normal-weight); 2) VPA was higher in Group (weight-loss-maintainer) than Group (always-normal-weight); 3) no differences in MPA and LPA between groups. 4) Most Group (always-normal-weight) engaged in 30–60 MVPA min/d; 5) Most Group (weight-loss-maintainer) engaged in >60 MVPA min/d |
|
| cross-sectional | New zealand | 275 | A: ActiGraph w-GT3X, Acti-Watch; triaxial. Duration (min/d): MVPATPA (cpm/d) |
| Regression: adjusted for age and socioeconomic level. 1) TPA was favorably associated with %BF and VAT; had no association with WC or BMI; 2) MVPA was favorably associated with %BF, VAT, WC and BMI |
|
| cross-sectional | United States of America | 201 | A: Actigraph AM7164, uniaxialDuration (min/d): LPA, MVPATPA (min/d ≥ 100 counts) |
| Regression: adjusted for age, BMI, race-ethnicity, education, SB1) LPA, MVPA had no association with VAT; 2) TPA was favorably associated with VAT |
|
| cross-sectional | United States | 248 | A: CSA; uniaxial. Duration (min/d): MPA, VPA; TPA (cpm/d) |
| Regression: age, menopausal status, education, and health status. 1) TPA and MPA had no association with %BF or WC in both ethic groups; 2) VPA was favorably associated with %BF and WC in Group (White); had no association in Group (Chinese) |
|
| cross-sectional | United States | 1,594 | A: AM-7164; uniaxial. Duration (min/d): MVPA bout (10min), MVPA non-bout |
| Regression: adjusted age, age-squared, race/ethnicity, smoking, and health status.1) MVPA bouts was favorably associated with BMI and WC; 2) MVPA non-bouts had no association with BMI and WC; 3) The strength of association with decreased BMI was nearly 7 times greater for MVPA bout than for MVPA non-bouts; 4) The strength of association with decreased WC was nearly 5 times greater for MVPA bout than for MVPA non-bouts |
|
| cross-sectional | United States | 80 | P: Yamax Digi-Walker SW-200. Steps (n/d) |
| Correlation: adjusted for age. 1) Steps/d was favorably associated with BMI, %BF, WC; ANOVA:1) Group (<6000steps/d) had higher BMI than Group (6,000–9,999) and Group (≥10,000); 2) Group (≥10,000) had the lowest %BF, and WC among three groups |
|
| cross-sectional | Finland | 837 | P: Walking style One, HJ-152R-E Steps (n/d) |
| ANOVA: 1) Group (steps/d > 8,765) had lower BMI than Group (Steps/d < 6,317) |
|
| cross-sectional | United States | 278 | A: CSA; uniaxial. TPA (counts) (min/w). Intensity and duration of PA (counts/10min) |
| Regression: adjusted for BM, and energy intake. 1) TPA was favorably associated with %BF; 2) The intensity and duration were favorably associated with %BF. |
|
| cross-sectional | Australia | 158 | P: Yamax Digiwalker SW700. Steps (n/d) |
| ANOVA: 1) Group (Fewer Steps/day) had higher BMI. |
|
| cross-sectional | United States | 60 | A: Actigraph GT1M; uniaxial meet MVPA/do not meet MVPA (duration) |
| t-test: 1) No differences in BMI, FM, %BF or WC between groups |
|
| cross-sectional | United States | 60 | A: Actigraph GT1M; uniaxial Steps (n/d) |
| correlation: 1) Steps/d had no association with WC |
|
| cross-sectional | multi-country | 3,027 | A: ActiGraph 7,164/71,256, GT1M, ActiTrainer, GT3X; uniaxialandtriaxial. Duration (min/d): MVPATPA (cpm/d) |
| Regression: socio-demographic status and accelerometer wear time. 1) MVPA and TPA was favorably associated with BMI with country-specific associations |
|
| cohort study/cross-sectional | United States | 228 | A: ActiGraph; uniaxial The LPA, MPA, VPA groups based on the average of the highest 7 epochs (10min); The increased-, maintained- and decreased- intensity groups based on changes of PA intensity group from baseline to follow-up |
| ANCOVA: adjusted for age and TPA. 1) Group (VPA) had lower BF% than Group (MPA) or Group (LPA); 2) no difference in BF% between Group (MPA) and Group (LPA); 3) Group (decreased intensity) had a higher proportion of having a higher %BF at follow-up than Group (maintained intensity) and Group (increased intensity) |
Note: A: accelerometer; BMI, body mass index; FM, fat mass; HAF, high abdominal fat; METs, metabolic equivalents; MPA, moderate intensity physical activity; MVPA, moderate to vigorous intensity physical activity; NAF, normal abdominal fat; P, pedometer; PA, physical activity; SB, sedentary behaviors; TPA, total physical activity; VAT, visceral adipose tissue; VPA, vigorous physical activity; WC, waist circumference; %BF, percentage body fat.
Characteristics of intervention studies.
| References | Study design | Country | Sample size | Intervention | PA measure | Health outcome | Association |
|---|---|---|---|---|---|---|---|
|
| random experiment | United States | 92 | 24-weeks incremental walking program; Group 1 ( | A: ActiGraph GT3x; triaxial. P: Omeron HJ-720-IT; Duration (min/d): LPA, MVPA. Steps, Aerobic steps (n/d) |
| ANOVA: 1) Steps/d increased from baseline in all three Groups, with a significant intervention effect between groups; 2) LPA increased from baseline only in Group 3, with no effect for groups; 3) MVPA and aerobic steps/d increased from baseline in all three Groups, with a significant main effect for groups between Group 2&3 and Group 1; 4) BMI increased from baseline only in Group 1; 5) %BF and VAT mass and volume had no change in all three groups; 6) FM increased from baseline in Group 2&3; 7) no follow-up differences in all parameters between groups |
|
| randomized controlled trial | Turkey | 84 | 3-months pedometer-based walking program. Group 1 (n = 45): with pedometer. CONT (n = 39): without pedometer | P: Voit 3 days. Steps (n/d) |
| ANCOVA: baseline BM, BMI, %BF. 1) BMI, %BF, WC decreased in Group 1; had no change in CONT; 2) ΔBMI, Δ%BF, ΔWC were larger in Group 1 compared to CONT |
|
| Quasi-experimental design | UAE | 52 | 9-weeks pedometer-based walking program, asked to walk 10,000 steps per day | P: KenzLifeCoder e-step. Steps (n/d) |
| Correlation: 1) After intervention, steps/d was favorably associated with BMI, FM, and %BF; had no association with VAT or WC t-test:1) After intervention, FM, BMI, %BF, VAT, WC decreased; 2) In Group (18 ≤ BMI<25), after intervention, BMI and FM decreased; no changes in %BF, VAT or WC; 3) In Group (BMI≥25), after intervention, BMI, FM, %BF, WC, and VAT decreased |
|
| randomized controlled trial | United Kingdom | 58 | 24-weeks PA interventionGroup 1 ( | A: ActiGraph GT3X+; triaxial %duration of LPA, MVPA |
| ANOVA: 1) Changes in WC was significantly greater in Group 2 at 24 weeks, compared with CONT; 2) There was a trend for greater reductions in FM in Group 2 vs. CONT ( |
|
| random experiment | United States | 44 | 12-weeks exercise interventionGroup 1: asked to walk 10,000 steps/dGroup 2: asked to walk 10,000 steps/d + RT 2days/w (3 sets of 8–12 repetitions of 10 resistance exercises for the lower and upper body) | P: New Lifestyles Digi-Walker SW-200 Steps (n/d) |
| ANOVA: 1) Steps/d increased from baseline in both groups; 2) No changes in all parameters after intervention in Group 1; 3) WC, %BF and FM decreased after intervention in Group 2 |
|
| randomized controlled trial | United States | 24 | 24-weeks pedometer-based walking programGroup 1: provided with a target number of steps that would lead to a 3-km increase in daily walking; CONT: maintain current physical activity and subsequently wore a pedometer 1 week each month to document their walking | P: Yamax SW200 pedometer Steps (n/d) |
| ANOVA: 1) Steps/d increased from baseline in Group 1 compared with CONT; 2) %BF had no change in either group after intervention |
|
| Quasi-experimental design | United States | 77 | 12-weeks incremental walking program; asked to increase steps/d by 10% per week; the progression was reduced to a 3% when steps/d reached 10,000Group 1: improved steps/d by 3,000 or greater; CONT: stopped participating or did not achieve step improvement level | P: Sportline 330 Steps (n/d) |
| ANOVA: 1) BMI decreased after intervention in Group 1 compared with CONT; 2) WC decreased after intervention in Group 1 |
|
| random experiment | Australia | 28 | 12-weeks walking program; Group 1: asked to undertake 30 min of walking/day; with sealed pedometerGroup 2: asked to accumulate 10,000 steps/d, with unsealed pedometer | P: Yamax Digi-Walker SW-200 Steps (n/d) |
| ANOVA: 1) Steps increased in both groups after intervention with between-group effects.2) no changes in BMI, %BF, WC in either group after intervention |
|
| random experiment | Japan | 17 | 12-weeks cycling training. Group 1 ( | A: Lifecorder; uniaxial Intensity LPA (<4METs), MPA (4-6METs), VPA (>6METs) (min/d) |
| ANOVA: 1) BMI decreased after intervention in Group 2 |
|
| Quasi-experimental design | United States | 18 | 4-weeks control period followed by 8-weeks walking program | P: Yamax Digi-Walker SW-200 Steps (n/d) |
| ANOVA: 1) Steps/d increased during intervention period; 2) BMI, %BF, and WC had no change |
Note: A: accelerometer; BMI, body mass index; CONT, control group; FM, fat mass; HRR, heart rate reverse; METs, metabolic equivalents; MPA, moderate intensity physical activity; MVPA, moderate to vigorous intensity physical activity; P, pedometer; PA, physical activity; RT, resistance training; SB, sedentary behaviors; TPA, total physical activity; VAT, visceral adipose tissue; VPA, vigorous physical activity; WC, waist circumference; %BF, percentage body fat.
FIGURE 2Forest plot of correlation between steps and adiposity outcomes. Overall pooled correlation for random effects model represented by black diamond. Note: BMI, body mass index; FM, fat mass; WC, waist circumference.
FIGURE 3Forest plot of correlation between TPA and %BF. Overall pooled correlation for random effects model represented by black diamond. Note: TPA, total physical activity, %BF, percentage body fat.
FIGURE 4Forest plot of correlation between MVPA and adiposity outcomes. Overall pooled correlation for random effects model represented by black diamond. Note: BMI, body mass index; MVPA, moderate to vigorous physical activity; VAT, visceral adiposity tissue; WC, waist circumference.
FIGURE 5Forest plot of the difference between post- and pre- walking intervention on body mass index. Overall pooled effect for random effects model represented by black diamond.
FIGURE 6Forest plot of the difference between post- and pre- walking intervention on body fat%. Overall pooled effect for random effects model represented by black diamond.
FIGURE 7Forest plot of the difference between post- and pre- walking intervention on waist circumference. Overall pooled effect for random effects model represented by black diamond.
FIGURE 8Forest plot of the difference between post- and pre- walking intervention on visceral adiposity tissue. Overall pooled effect for random effects model represented by black diamond.